Lutsenko Svetlana
Department of Biochemistry and Molecular Biology, Oregon Health and Science University, Portland, OR 97239, USA.
Biochem Soc Trans. 2008 Dec;36(Pt 6):1233-8. doi: 10.1042/BST0361233.
Wilson's disease is a severe human disorder of copper homoeostasis. The disease is associated with various mutations in the ATP7B gene that encodes a copper-transporting ATPase, and a massive accumulation of copper in the liver and several other tissues. The most frequent disease manifestations include a wide spectrum of liver pathologies as well as neurological and psychiatric abnormalities. A combination of copper chelators and zinc therapy has been used to prevent disease progression; however, accurate and timely diagnosis of the disease remains challenging. Similarly, side effects of treatments are common. To understand better the biochemical and cellular basis of Wilson's disease, several animal models have been developed. This review focuses on genetically engineered Atp7b(-/-) mice and describes the properties of these knockout animals, insights into the disease progression generated using Atp7b(-/-) mice, as well as advantages and limitations of Atp7b(-/-) mice as an experimental model for Wilson's disease.
威尔逊氏病是一种严重的人体铜稳态紊乱疾病。该疾病与编码铜转运ATP酶的ATP7B基因的各种突变有关,导致肝脏和其他几种组织中铜的大量积累。最常见的疾病表现包括广泛的肝脏病变以及神经和精神异常。铜螯合剂和锌疗法联合使用可预防疾病进展;然而,准确及时地诊断该疾病仍然具有挑战性。同样,治疗的副作用也很常见。为了更好地理解威尔逊氏病的生化和细胞基础,已经开发了几种动物模型。本综述重点关注基因工程Atp7b(-/-)小鼠,描述这些基因敲除动物的特性、利用Atp7b(-/-)小鼠对疾病进展的深入了解,以及Atp7b(-/-)小鼠作为威尔逊氏病实验模型的优缺点。